Current and future use of umifenovir in patients with COVID-19

At the time of print, the evidence for using umifenovir in COVID-19 is mainly theoretical. The published clinical trials have contradicting results. The decision to use umifenovir in COVID-19 should be individualized, considering the “experimental” nature of this treatment.

Saved in:
Bibliographic Details
Published inKachestvennai͡a︡ klinicheskai͡a︡ praktika no. 4S; pp. 75 - 80
Main Authors Kiselev, Yu. Yu, Zagorodnikova, K. A., Ivashchenko, D. V., Krykov, A. V., Sychev, I. N., Matveev, A. S., Mirzaev, K. B., Otdelenov, V. A., Tsvetov, V. M., Dmitriev, A. V., Poroikov, V. V., Sychev, D. A.
Format Journal Article
LanguageEnglish
Published Izdatelstvo OKI 28.10.2020
Subjects
covid-19
коронавирус
умифеновир
Online AccessGet full text

Cover

More Information
Summary:At the time of print, the evidence for using umifenovir in COVID-19 is mainly theoretical. The published clinical trials have contradicting results. The decision to use umifenovir in COVID-19 should be individualized, considering the “experimental” nature of this treatment.
ISSN:2588-0519
2618-8473
DOI:10.37489/2588-0519-2020-S4-75-80